European Foundation For Study Of Chronic Liver Failure
Clinical trials sponsored by European Foundation For Study Of Chronic Liver Failure, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a Two-Drug combo keep cirrhosis patients out of the hospital? Results expected Oct 2026 (estimated)
- Massive study aims to improve liver transplant decisions Results expected Dec 2026 (estimated)
-
Can a Two-Drug combo keep cirrhosis patients out of the hospital?
Disease control Recruiting nowResearchers are testing whether combining human albumin and enoxaparin is safe and effective for people with decompensated cirrhosis who are well enough to leave the hospital. The trial enrolls about 90 adults with severe liver scarring and recent complications. Participants rece…
Phase 2 • Sponsor: European Foundation for Study of Chronic Liver Failure • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
Massive study aims to improve liver transplant decisions
Knowledge-focused Recruiting nowThis study follows 3000 adults with severe liver failure who are being considered for a liver transplant. Researchers want to learn which patients benefit most from the procedure and how to improve survival. The goal is to better guide doctors in making this life-saving decision.
Sponsor: European Foundation for Study of Chronic Liver Failure • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC